OBSTRUCTIVE UROPATHY side effect
What is OBSTRUCTIVE UROPATHY ?Drugs associated with OBSTRUCTIVE UROPATHY
AVONEX BONIVA BYETTA CRIXIVAN EXELON MYCOPHENOLATE NAPROXEN ORLISTAT TOPOTECANOBSTRUCTIVE UROPATHY : Orlistat Side Effects Report #5682786-1
Consumer or non-health professional from UNITED KINGDOM reported ORLISTAT problem on Mar 19, 2008. Female patient, 29 years of age, weighting 224.0 lb, was diagnosed with obesity, hypertension, asthma, gastrointestinal disorder, benign intracranial hypertension and was treated with ORLISTAT. After drug was administered, patient experienced the following problems/side effects: obstructive uropathy, . ORLISTAT dosage: unknown. During the same period patient was treated with VERAPAMIL, ACCOLATE, SOLIFENACIN SUCCINATE, DOMPERIDONE, AMITRIPTYLINE, ACETAZOLAMIDE, OMEPRAZOLE, TRIMETOPRIM. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Crixivan Side Effects Report #5557782-5
CRIXIVAN problem was reported by a Physician from SPAIN on Dec 05, 2007. Male patient, child 10 years of age, was diagnosed with hiv infection and was treated with CRIXIVAN. After drug was administered, patient experienced the following problems/side effects: obstructive uropathy, . CRIXIVAN dosage: unknown. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Mycophenolate Side Effects Report #5411265-1
Physician from NETHERLANDS reported MYCOPHENOLATE MOFETIL problem on Aug 01, 2007. Male patient, 67 years of age, was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: obstructive uropathy, reperfusion injury, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SEPTRIN, FUROSEMIDE, ALOPURINOL, AUGMENTIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Avonex Side Effects Report #5428664-4
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 13, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: obstructive uropathy, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Boniva Side Effects Report #5668950-6
Consumer or non-health professional from UNITED STATES reported BONIVA problem on Mar 07, 2008. Female patient, 74 years of age, was diagnosed with osteoporosis and was treated with BONIVA. After drug was administered, patient experienced the following problems/side effects: incisional hernia, obstructive uropathy, . BONIVA dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, VITAMIN NOS, VICODIN, PERCOCET. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Byetta Side Effects Report #5553804-6
BYETTA problem was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis, obstructive uropathy, renal failure acute, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Exelon Side Effects Report #5650765-6
Physician from UNITED STATES reported EXELON problem on Feb 25, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, renal failure acute, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Exelon Side Effects Report #5614988-4
EXELON problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Exelon Side Effects Report #5624919-9
Physician from UNITED STATES reported EXELON problem on Feb 05, 2008. Male patient, 76 years of age, weighting 148.0 lb, was diagnosed with dementia alzheimer's type, hypertension, hyperlipidaemia, depression and was treated with EXELON. After drug was administered, patient experienced the following problems/side effects: catheter placement, depressed level of consciousness, obstructive uropathy, prostatic obstruction, urine output decreased, . EXELON dosage: unknown. During the same period patient was treated with ATENOLOL, LIPITOR, CITALOPRAM HYDROBROMIDE, PERCOCET, TYLENOL. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Topotecan Side Effects Report #5481556-7
TOPOTECAN problem was reported by a Health Professional from UNITED STATES on Oct 05, 2007. Female patient, weighting 268.5 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine abnormal, female genital tract fistula, obstructive uropathy, prothrombin time prolonged, . TOPOTECAN dosage: 18 MG. During the same period patient was treated with COUMADIN, MIRALAX, SENOKOT, VICODIN. Patient was hospitalized. Patient recovered.
OBSTRUCTIVE UROPATHY : Naproxen Side Effects Report #5470159-6
Health Professional from UNITED STATES reported NAPROXEN problem on Sept 11, 2007. Female patient, 38 years of age, was diagnosed with arthralgia and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, nephropathy toxic, obstructive uropathy, renal atrophy, renal impairment, renal papillary necrosis, ureteral stent insertion, . NAPROXEN dosage: 325 MG DAILY,. During the same period patient was treated with PARACETAMOL, DIPHENHYDRAMINE, METOCLOPRAMIDE, FENOFIBRATE, VENLAFAXINE, PANTOPRAZOLE, HYDROCHLORIC ACID. Patient was hospitalized. Patient recovered.